Table 3A. Grade 3 and 4 toxicities attributed to aflibercept and temozolomide for Arm 1.
| Adverse Event | Aflibercept DL0 | Aflibercept DL1 | Temozolomide (DL0) | Temozolomide (DL1) |
|---|---|---|---|---|
| Abdominal pain | 1 | |||
| Alanine aminotransferase increase | 1 | |||
| Aspartate aminotransferase increase | 1 | |||
| Alkaline phosphatase increase | 1 | |||
| Bilirubin increase | 2 | 1 | ||
| Gamma glutamyl transferase increase | 1 | |||
| Arthralgia | 1 | 1 | ||
| Colonic perforation | 1 | |||
| Colitis | 1 | |||
| Dehydration | 1 | |||
| Fatigue | 1 | 1 | ||
| Headache | 1 | |||
| Hypertension | 1 | |||
| Hypokalemia | 1 | |||
| Hyponatremia | 1 | |||
| Seizure | 3 | 3 | ||
| Nausea | 1 | |||
| Lung infection | 1 | |||
| Peripheral nerve infection | 1 | |||
| Urinary tract infection | 1 | |||
| Vascular access complication | 1 | 1 | ||
| Leukopenia | 1 | 1 | ||
| Lymphopenia | 3 | 4 | ||
| Neutropenia | 2 | 2 | ||
| Thrombocytopenia | 2 | 2 | ||
| Investigations (other) | 1 |